Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2026)

Elanco Animal Health has disclosed Net Cash Flow across 10 years of filings, most recently posting $93.0 million for Q2 2026.

• In Q2 2026, Net Cash Flow rose 272.0% year-over-year to $93.0 million; the TTM figure through Jun 2026 stood at -$28.0 million (down 120.59% YoY), while the FY2025 annual figure was $6.0 million, down 97.1% from the prior year.
• Net Cash Flow came in at $93.0 million for Q2 2026 at Elanco Animal Health, up from -$112.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $179.0 million in Q2 2022 to a low of -$291.0 million in Q1 2022.
• Average Net Cash Flow over 5 years is -$3.5 million, with a median of $8.5 million recorded in 2023.
• Year-over-year, Net Cash Flow soared 1220.0% in 2024 and tumbled 1020.0% in 2026.
• Over 5 years, Net Cash Flow stood at -$147.0 million in 2022, then surged by 88.44% to -$17.0 million in 2023, then soared by 423.53% to $55.0 million in 2024, then slumped by 52.73% to $26.0 million in 2025, then jumped by 257.69% to $93.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $93.0 million in Q2 2026, -$112.0 million in Q1 2026, and $26.0 million in Q4 2025.